Even though our data from clinical OS patients’ samples and cancer databases support the findings from cells and the xenograft model, other methodologies including the PDX model or transgenic mice (e.g. LAPTM4B KO mice) were warranty to illustrate LAPTM4B functions and roles in osteosarcoma progression in the future study. This evidence concerns the gene LAPTM4B and cancer.